ClinConnect ClinConnect Logo
Search / Trial NCT06898671

Language Outcomes, Mechanisms, and Trajectories in Adults With and Without Developmental Language Disorder

Launched by UNIVERSITY OF IOWA · Mar 25, 2025

Trial Information

Current as of April 26, 2025

Recruiting

Keywords

Language Profiles Language Processing Adult Language Disorders Typical Adult Language

ClinConnect Summary

This clinical trial is studying how adults with Developmental Language Disorder (DLD) compare to those with typical language skills, focusing on their long-term language abilities and the underlying reasons for any differences. Researchers are looking at data from a previous study that followed individuals from childhood into adulthood, specifically targeting those aged 30 to 35. They want to see how language skills evolve over time, whether some individuals with DLD catch up to their peers, or if others may experience difficulties or remain stable in their language abilities.

To participate, you need to be an adult aged 28 to 40 who has either DLD or typical language skills and has previously taken part in the Iowa Longitudinal Study. Participants will undergo various assessments to understand their language performance and cognitive skills. Importantly, you should have normal or corrected vision and hearing, and you should not have a history of brain injury or other developmental disabilities. If you join the study, you can expect to contribute to important research that helps improve our understanding of language development and communication challenges in adults.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults with Developmental Language Disorder (DLD) and those with typical language (TL) between the ages of 28 and 40 years who participated in the Iowa Longitudinal Study(NIH-DC-19-90 \& P50 DC002746; IRB# 200106051, "Collaboration on Specific Language Impairment".)
  • Aged 30-35
  • Normal or corrected to normal vision
  • Normal hearing
  • Exclusion Criteria:
  • history of brain injury
  • history of neural developmental disabilities
  • not monolingual

About University Of Iowa

The University of Iowa, a leading academic and research institution, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and researchers to investigate cutting-edge therapies and treatments across various medical fields. Committed to ethical research practices and patient-centered care, the University of Iowa strives to contribute significantly to medical knowledge and improve health outcomes through rigorous scientific inquiry and community engagement.

Locations

Iowa City, Iowa, United States

Patients applied

0 patients applied

Trial Officials

Stewart McCauley, PhD

Principal Investigator

University of Iowa

Si On Yoon, PhD

Principal Investigator

University of Iowa

Philip Combiths, PhD

Principal Investigator

University of Iowa

J. Bruce Tomblin, PhD

Principal Investigator

University of Iowa

Jacob Oleson, PhD

Principal Investigator

University of Iowa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported